序号 |
标题 |
次数 |
作者 |
发布时间 |
78796 |
NH2-PEG-DOTA-PEG-NH2,氨基-聚乙二醇-DOTA-聚乙二醇-氨基 |
96 |
wyh |
2024-12-03 |
78797 |
P(VDF-TrFE)@DOTA-Gd@RGD ,复合压电纳米粒子 |
107 |
wyh |
2024-12-03 |
78798 |
双吡啶基配体3,6-二(4-吡啶基)-1,2,4,5-四嗪(DPT) |
129 |
WYQ |
2024-12-03 |
78799 |
四嗪-聚乙二醇-N-羟基琥珀酰亚胺酯偶联1,2-二硬脂酰基-sn-甘油基-3-磷酸乙醇胺-N-[氨基(聚乙二醇)-2000](DSPE-PEG2k-NH2) |
88 |
WYQ |
2024-12-03 |
78800 |
修饰Tetrazine的脂质分子(DSPE-PEG2k-PEG5-Tetrazine) |
110 |
WYQ |
2024-12-03 |
78801 |
3,6-双硝基胍基-1,2,4,5-四嗪双胍盐(G2DNGTz) |
96 |
WYQ |
2024-12-03 |
78802 |
3,6-双(3-硝基-1,2,4-噁二唑-5-胍基)-1,2,4,5-四嗪(NOG2Tz) |
119 |
WYQ |
2024-12-03 |
78803 |
(68)Ga-NOTA-Tz)结合了放射性同位素^(68)Ga |
94 |
WYQ |
2024-12-03 |
78804 |
HPMADOTAGd,DOTA偶联多聚HPMAGd磁共振成像探针 |
109 |
wyh |
2024-12-03 |
78805 |
1,2,3,4-四嗪-1,3-二氧化物(Benzo-1,2,3,4-tetrazine-1,3-dioxide) |
146 |
WYQ |
2024-12-03 |
78806 |
DOTAtEBTMTP1,DOTA修饰tEBTMTP1化合物 |
77 |
wyh |
2024-12-03 |
78807 |
3,6二氨基-1,2,4,5-四嗪-1,4-二氧化物(DATZO2) |
97 |
WYQ |
2024-12-03 |
78808 |
DOTA-VEGFDEE ,DOTA偶联突变体VEGFDEE |
75 |
wyh |
2024-12-03 |
78809 |
3,6-双(3,5-二甲基-吡唑-1-酰基)-1,2,4-四嗪(BT) |
89 |
WYQ |
2024-12-03 |
78810 |
DOTA-Cy5.5-NP,聚合物修饰上双功能螯合剂DOTA和近红外染料Cy5.5 |
94 |
wyh |
2024-12-03 |
78811 |
1,2,3,4-四嗪-1,3-二氧化物;Benzo-1,2,3,4-tetrazine-1,3-dioxide |
111 |
WYQ |
2024-12-03 |
78812 |
DOTA-dPEG2-R954,DOTA偶联R954衍生物 |
88 |
wyh |
2024-12-03 |
78813 |
3,6二氨基-1,2,4,5-四嗪-1,4-二氧化物(DATZO2);3,6-Diamino-1,2,4,5-tetrazine-1,4-dioxide |
83 |
WYQ |
2024-12-03 |
78814 |
3,6-双(3,5-二甲基-吡唑-1-酰基)-1,2,4-四嗪(BT);3,6-bis ( 3,5-dimethyl-pyrazol-1-oyl)-1,2,4,5-tetrazine |
103 |
WYQ |
2024-12-03 |
78815 |
3,6-双胍基-1,2,4,5-四嗪(DGTZ) |
125 |
WYQ |
2024-12-03 |
78816 |
氨基酸衍生物L-4-四嗪-苯丙氨酸 |
121 |
WYQ |
2024-12-03 |
78817 |
3,6-双(1-氢-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
90 |
WYQ |
2024-12-03 |
78818 |
3-氨基-6-(3,5-二甲基吡唑基-1-基)-1,2,4-三唑[4,3-b]-1,2,4,5-四嗪(ADTTz) |
93 |
WYQ |
2024-12-03 |
78819 |
3-[(对甲氧基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DPMHT) |
110 |
WYQ |
2024-12-03 |
78820 |
3-[(3-甲氧基-4-羟基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DMPT) |
164 |
WYQ |
2024-12-03 |
78821 |
[Tc-99m]HYNIC-PEG(11)-Tz;[Tc-99m]标记联肼尼克酰胺多肽--PEG11-四嗪 |
87 |
WYQ |
2024-12-03 |
78822 |
maleimide-PEG-NHS ,马来酰亚胺-聚乙二醇-活性酯 |
81 |
wyh |
2024-12-03 |
78823 |
氨基聚乙二醇功能化的金纳米粒,AuNP-PEG-NH |
133 |
wyh |
2024-12-03 |
78824 |
Gd-DOTA修饰星形两亲性葡聚糖胶束 |
79 |
wyh |
2024-12-03 |
78825 |
IRFE-PEG-DOTA(IPD), 近红外二区(NIR II)有机染料 |
151 |
wyh |
2024-12-03 |
78826 |
[18F]FN-PEG4-Tz-TCO-GK-PEG4-5F7 ([18F]FN-GK-5F7) |
101 |
WYQ |
2024-12-03 |
78827 |
64Cu]Cu-NOTA-PEG7-H-Tz |
114 |
WYQ |
2024-12-03 |
78828 |
DOTA-PEG-DSPE ,DOTA-聚乙二醇-磷脂 |
84 |
wyh |
2024-12-03 |
78829 |
3,6-二氨基-1,2,4,5-四嗪(DATZ) |
75 |
WYQ |
2024-12-03 |
78830 |
DOTA-PEG(4)-BBN ;DOTA-四聚乙二醇-铃蟾肽 |
78 |
wyh |
2024-12-03 |
78831 |
3,6-二氨基-1,2,4,5-四嗪-1,4-二氧化物 |
125 |
WYQ |
2024-12-03 |
78832 |
1,6-二氢-1,2,4,5-四嗪化合物(1,6-Dihydro-1,2,4,5-Tetrazines) |
171 |
WYQ |
2024-12-03 |
78833 |
TCO-CC49 ,TCO功能化CC49抗体 |
108 |
wyh |
2024-12-03 |
78834 |
[111In]In-DOTA-PEG11-BisPy-Tz |
98 |
WYQ |
2024-12-03 |
78835 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
93 |
WYQ |
2024-12-03 |
78836 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
89 |
WYQ |
2024-12-03 |
78837 |
3,6-双(2-吡啶基)-1,2,4,5-四嗪(bptz);3,6-bis(2-pyridyl)-1,2,4,5-tetrazine |
98 |
WYQ |
2024-12-03 |
78838 |
(DOTA)5-decalysine , (DOTA)5-十氢赖氨酸 |
78 |
wyh |
2024-12-03 |
78839 |
3,6-dihydrazino-1,2,4,5-tetrazine(DHT) |
107 |
WYQ |
2024-12-03 |
78840 |
5-TAMRA-Tz;S-四嗪近红外花菁染料;5-TAMRA-tetrazine |
120 |
WYQ |
2024-12-03 |